Semaglutide is a GLP-1 analog that has been widely studied in metabolic and diabetes research. It functions by mimicking incretin hormones, which help regulate blood sugar levels and reduce appetite. Research models have shown Semaglutide can support weight regulation, improve insulin sensitivity, and contribute to a better understanding of energy balance. Its unique mechanism of action makes it a valuable subject of investigation in obesity and metabolic health research